For pemphigus vulgaris, post-RTX BAFF resurgence aligns with B cell recovery (101, 137, 138); sequential use of RTX-BLM or transmembrane activator and calcium modulator and cyclophilin ligand interactor agonists could limit autoreactivity. This evidence concerns the gene TNFSF13B and pemphigus vulgaris.